Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal butorphanol for prevention of sufentanil-induced cough during general anesthesia induction
ChiCTR2100049699Phase 4Not yet recruiting
- Sponsor
- Hunan Provincial People's Hospital
- Start
- Sep 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butorphanol and sufentanil in cough (4 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoint: Incidence of coughing. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
butorphanolsufentanil
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR2100049699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049699.